SEARCH

SEARCH BY CITATION

References

  • AIELLO, E., VILLA-ABRILLE, M.C. & CINGOLANI, H.E. (2002). Autocrine stimulation of cardiac Na+–Ca2+ exchanger currents by endogenous endothelin released by angiotensin II. Circ. Res., 90, 374376.
  • ALLEN, I.S., COHEN, N.M., DHALLAN, R.S., GAA, S.T., LEDERER, W.J. & ROGERS, T.B. (1988). Angiotensin II increases spontaneous contractile frequency and stimulates calcium currents in cultured neonatal rat heart myocytes: insights into underlying biochemical mechanisms. Circ. Res., 62, 524534.
  • BLOM, N.A., GITTENBERGER-DE GROOT, A.C., DERUITER, M.C., POELMANN, R.E., MENTINK, M.M. & OTTENKAMP, J. (1999). Development of the cardiac conduction tissue in human embryos using HNK-1 antigen expression: possible relevance for understanding of abnormal atrial automaticity. Circulation, 99, 800806.
  • BOLDT, A., WETZEL, U., WEIGL, J., GARBADE, J., LAUSCHKE, J., HINDRICKS, G., KOTTKAMP, H., GUMMERT, J.F. & DHEIN, S. (2003). Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease. J. Am. Coll. Cardiol., 42, 17851792.
  • BOSTON, D.R., KOYAMA, T., RODRIGUEZ-LARRAIN, J., ZOU, A., SU, Z. & BARRY, W.H. (1998). Effects of angiotensin II on intracellular calcium and contracture in metabolically inhibited cardiomyocytes. J. Pharmacol. Exp. Ther., 285, 716723.
  • CHEN, S.A., CHANG, M.S., CHIANG, B.N., CHENG, K.K. & LIN, C.I. (1991). Electromechanical effects of angiotensin in human atrial tissues. J. Mol. Cell Cardiol., 23, 483493.
  • CHEN, S.A., HSIEH, M.H., TAI, C.T., TSAI, C.F., PRAKASH, V.S., YU, W.C., HSU, T.L., DING, Y.A. & CHANG, M.S. (1999). Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation, 100, 18791886.
  • CHEN, Y.C., CHEN, S.A., CHEN, Y.J., CHANG, M.S., CHAN, P. & LIN, C.I. (2002). Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. J. Am. Coll. Cardiol., 39, 366372.
  • CHEN, Y.J., CHEN, S.A., CHANG, M.S. & LIN, C.I. (2000). Arrhythmogenic activity of cardiac muscle in pulmonary vein of the dog: implication for the genesis of atrial fibrillation. Cardiovasc. Res., 48, 265273.
  • CHEN, Y.J., CHEN, S.A., CHEN, Y.C., YEH, H.I., CHAN, P., CHANG, M.S. & LIN, C.I. (2001). Effects of rapid atrial pacing on the arrhythmogenic activity of single cardiomyocytes from pulmonary veins: implication in initiation of atrial fibrillation. Circulation, 104, 28492854.
  • DALEAU, P. & TURGEON, J. (1994). Angiotensin II modulates the delayed rectifier potassium current of guinea pig ventricular myocytes. Pflugers Arch, 427, 553555.
  • ENOUS, R. & OPIE, L.H. (1994). Effect of the angiotensin-converting enzyme inhibitor, perindoprilat, and of angiotensin-II on the transient inward current of rabbit ventricular myocytes. Cardiovasc. Drugs Ther., 8, 647651.
  • FEINBERG, W.M., BLACKSHEAR, J.L., LAUPACIS, A., KRONMAL, R. & HART, R.G. (1995). Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch. Intern. Med., 155, 469473.
  • GOETTE, A., ARNDT, M. & ROCKEN, C. (2000a). Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation, 101, 26782681.
  • GOETTE, A., STAACK, T., ROCKEN, C., ARNDT, M., GELLER, J.C., HUTH, C., ANSORGE, S., KLEIN, H.U. & LENDECKEL, U. (2000b). Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J. Am. Coll. Cardiol., 35, 16691677.
  • GONDO, N., KUMAGAI, K., NAKASHIMA, H. & SAKU, K. (2001). Angiotensin II provokes cesium-induced ventricular tachyarrhythmias. Cardiovasc. Res., 49, 381390.
  • HAISSAGUERRE, M., JAIS, P., SHAH, D.C., TAKAHASHI, A., HOCINI, M., QUINIOU, G., GARRIGUE, S., LE MOUROUX, A., LE METAYER, P. & CLEMENTY, J. (1998). Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med., 339, 659666.
  • HOCINI, M., HO, S.Y., KAWARA, T., LINNENBANK, A.C., POTSE, M., SHAH, D., JAIS, P., JANSE, M.J., HAISSAGUERRE, M. & DE BAKKER, J.M. (2002). Electrical conduction in canine pulmonary veins: electrophysiological and anatomic correlation. Circulation, 105, 24422448.
  • LOUCH, W.E., FERRIER, G.R. & HOWLETT, S.E. (2000). Losartan improves recover of contraction and inhibits transient inward current in a cellular model of cardiac ischemia and reperfusion. J. Pharmacol. Exper. Ther., 295, 697704.
  • MADRID, A.H., BUENO, M.G., REBOLLO, J.M., MARIN, I., PENA, G., BERNAL, E., RODRIGUEZ, A., CANO, L., CANO, J.M., CABEZA, P. & MORO, C. (2002). Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation, 106, 331336.
  • MIYATA, A., ZIPES, D.P., HALL, S. & RUBART, M. (2002). KB-R7943 prevents acute, atrial fibrillation-induced shortening of atrial refractoriness in anesthetized dogs. Circulation, 106, 14101419.
  • NAKASHIMA, H., KUMAGAI, K., URATA, H., GONDO, N., IDEISHI, M. & ARAKAWA, K. (2000). Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation, 101, 26122617.
  • PAPPONE, C., ROSANIO, S., ORETO, G., TOCCHI, M., GUGLIOTTA, F., VICEDOMINI, G., SALVATI, A., DICANDIA, C., MAZZONE, P., SANTINELLI, V., GULLETTA, S. & CHIERCHIA, S. (2000). Circumferential radiofrequency ablation of pulmonaryvein ostia: a new anatomic approach for curing atrial fibrillation. Circulation, 102, 26192628.
  • PEREZ-LUGONES, A., MCMAHON, J.T., RATLIFF, N.B., SALIBA, W.I., SCHWEIKERT, R.A., MARROUCHE, N.F., SAAD, E.B., NAVIA, J.L., MCCARTHY, P.M., TCHOU, P., GILLINOV, A.M. & NATALE, A. (2003). Evidence of specialized conduction cells in human pulmonary veins of patients with atrial fibrillation. J. Cardiovasc. Electrophysiol., 14, 803809.
  • SASAKI, M., FUJIMURA, A., HARADA, K., SUNAGA, K. & EBIHARA, A. (1996). Clinical pharmacology of multiple-dose losartan, an angiotensin II receptor antagonist, in patients with essential hypertension. J. Clin. Pharmacol., 36, 403408.
  • SUN, Y., RAMIRES, F.J.A. & WEBER, K.T. (1997). Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovasc. Res., 35, 138147.
  • YU, H., GAO, J., WANG, H., WYMORE, R., STEINBERG, S., MCKINNON, D., ROSEN, M.R. & COHEN, I.S. (2000). Effects of the rennin–angiotensin system on the currents I(to) in epicardial and endocardial ventricular myocytes from the canine heart. Circ. Res., 86, 10621068.
  • ZHOU, S., CHANG, C.M., WU, T.J., MIYAUCHI, Y., OKUYAMA, Y., PARK, A.M., HAMABE, A., OMICHI, C., HAYASHI, H., BRODSKY, L.A., MANDEL, W.J., TING, C.T., FISHBEIN, M.C., KARAGUEUZIAN, H.S. & CHEN, P.S. (2002). Nonreentrant focal activations in pulmonary veins in canine model of sustained atrial fibrillation. Am. J. Physiol. Heart Circ. Physiol., 283, H1244H1252.